Pharmacological inhibition of miR-126 enhances venetoclax activity in acute myeloid leukemia
Leying Zhang(City Of Hope National Medical Center), Le Xuan Truong Nguyen(City Of Hope National Medical Center), Amanda Blackmon(City Of Hope National Medical Center), Xin He(Sun Yat-sen University), Guido Marcucci(City Of Hope National Medical Center), Zhuo Li(Mayo Clinic in Florida), Lucy Ghoda(City Of Hope National Medical Center), Yu-Hsuan Fu(National Taiwan University), Ying‐Chieh Chen(City Of Hope National Medical Center), Xiyuan Lu(The University of Texas at Austin), Krystine Garcia‐Mansfield(Translational Genomics Research Institute), Patrick Pirrotte(Translational Genomics Research Institute), Melissa Valerio(City Of Hope National Medical Center), Khyatiben V. Pathak(Translational Genomics Research Institute), Bin Zhang(City Of Hope National Medical Center), Ling Li(Shandong University), Zhenhua Chen(Institute of Genetics and Developmental Biology), HyunJun Kang(City Of Hope National Medical Center), Ralf Buettner(City Of Hope National Medical Center), Wancheng Guo(City Of Hope National Medical Center), Dinh Hoa Hoang(City Of Hope National Medical Center), Ya‐Huei Kuo(City Of Hope National Medical Center)
Cited by 5
Related Papers
The lncRNA HOTAIRM1 regulates the degradation of PML-RARA oncoprotein and myeloid cell differentiation by enhancing the autophagy pathway
|Cell Death and Differentiation|2016|249
PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury
|Journal of Clinical Investigation|2005|230
Carbon Nanotubes Enhance CpG Uptake and Potentiate Antiglioma Immunity
|Clinical Cancer Research|2010|180
Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells
|Science Translational Medicine|2016|172